Vor Biopharma (VOR) Current Assets (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Current Assets data on file, last reported at $500.8 million in Q1 2026.

• On a quarterly basis, Current Assets rose 672.25% year-over-year to $500.8 million in Q1 2026; TTM through Mar 2026 was $500.8 million, a 672.25% increase from a year earlier, with the FY2025 full-year figure at $458.1 million, up 374.69% from the prior year.
• Current Assets for Q1 2026 stood at $500.8 million, up from $458.1 million in the prior quarter.
• Over the last five years, Current Assets for VOR reached as high as $500.8 million in Q1 2026 and fell as low as $64.8 million in Q1 2025.
• Historically, Current Assets has averaged $188.8 million across 5 years, with a median of $164.4 million in 2023.
• Across the five-year window, Current Assets tumbled 59.08% in 2024 and jumped 672.25% in 2026, its largest moves.
• Year by year, Current Assets stood at $237.0 million in 2022, then plunged by 40.58% to $140.8 million in 2023, then plunged by 31.46% to $96.5 million in 2024, then soared by 374.69% to $458.1 million in 2025, then advanced by 9.32% to $500.8 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $500.8 million in Q1 2026, $458.1 million in Q4 2025, and $172.5 million in Q3 2025.